SCHEMBL12570485

SCHEMBL12570485

CCC(C)N(CCOC)CC(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.34
▸ KCNA5 P22460 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12570480 0.84 — —
SCHEMBL12570498 0.82 — —
SCHEMBL14606836 0.82 PIK3CD (0.43) PIK3CDKCNA5
SCHEMBL12570431 0.77 — —
SCHEMBL12570454 0.74 DNM1 (0.35) —
SCHEMBL372755 0.69 PIK3CD (0.43) PIK3CD
SCHEMBL18776435 0.69 PIK3CD (0.33) PIK3CD
SCHEMBL12570492 0.68 MEN1 (0.36) PIK3CD
SCHEMBL17429832 0.67 PIK3CD (0.46) PIK3CD
SCHEMBL3436791 0.67 PIK3CD (0.46) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960554-B2 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2011-06-14 — — US disclosed
US-7534509-B2 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-05-19 — — US disclosed
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-09-27 — — US disclosed
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 PIK3CD 2826/4885KCNA5 1091/4885
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 PIK3CD 2826/4885KCNA5 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback